Key facts
- Treatment must be under a specialist, and your doctor will arrange heart tests before you start and keep checking your condition during treatment.
- Long-term use can cause fibrotic (scar tissue) reactions affecting the heart, lungs or abdomen. Tell your doctor straight away about breathing difficulty, chest pain, back pain, pelvic pain or swollen legs.
- It can cause extreme drowsiness and sudden sleep onset. Do not drive or use tools or machines until these symptoms have fully gone.
- Tell your doctor if you develop urges you cannot resist, such as gambling, excessive eating or spending, or an abnormally high sex drive.
- Take the tablets with meals to reduce nausea, vomiting and stomach pains, and talk to your doctor before stopping because symptoms may get worse.
Who should not take cabergoline
The leaflet says not to take it if any of these apply to you.
- Allergic to cabergoline, other ergot alkaloids (e.g. bromocriptine) or any other ingredient of the tablets
- Swelling of the hands and feet and high blood pressure during pregnancy (preeclampsia, eclampsia)
- Uncontrolled high blood pressure
- Ever diagnosed with fibrotic reactions affecting the lungs, back of the abdomen, kidneys or heart
- Will be treated for a long period and have or had fibrotic reactions (scar tissue) affecting the heart
Check with a doctor or pharmacist first
Tell them before you take it if any of these apply to you.
- Cardiovascular disease
- Stomach ulcer or bleeding in the gastrointestinal tract (can cause black faeces or vomiting with blood)
- History of serious mental disorder, particularly psychotic disorders
- Impaired liver or kidney function
- Raynaud's disease
- Low blood pressure (dizziness, particularly on standing up)
Show 7 moreShow fewer
- Serious chest complaint (e.g. pain in the chest when breathing, fluid in the lungs, inflammation or infection of the lungs)
- Fibrotic reactions (scar tissue) affecting the heart, lungs or abdomen; heart, lungs and kidneys are checked before long-term treatment and an echocardiogram is done before and during treatment
- Low blood pressure (postural hypotension) can occur, particularly in the first few days, and extra care is needed with other medicines that lower blood pressure
- Impulse control disorders such as addictive gambling, excessive eating or spending, abnormally high sex drive; your doctor may adjust or stop your dose
- Infertility can be reversed in women and pregnancy can occur before periods return to normal; regular pregnancy tests and suitable contraception are needed
- Just given birth: higher risk of high blood pressure, heart attack, convulsion, stroke or mental health problems, so blood pressure will be checked regularly
- Contains lactose; contact your doctor first if you have an intolerance to some sugars
How to take cabergoline
- Take exactly as your doctor has told you; the dose is set individually and increased gradually.
- Usual starting dose is 0.5 to 1 mg daily, rising to a maintenance dose of 2 mg up to 3 mg daily.
- Take the tablets with meals to reduce nausea, vomiting and stomach pains. The tablets can be divided into equal doses.
- If you miss a dose, take it when you remember unless the next dose is almost due, then skip it. Do not take a double dose.
Side effects
Get medical help straight away
The leaflet says to get help urgently, or to stop the medicine and speak to a doctor, if you notice any of these. In an emergency call 999.
- Heart valve and related disorders, e.g. pericarditis or pericardial effusion, with early symptoms such as difficulty breathing, shortness of breath, pounding heart, feeling faint, chest pain, back pain, pelvic pain or swollen legs, which may be first signs of fibrosis (very common)
- Allergic reaction: widespread itchy rash, difficulty breathing with or without wheezing, feeling faint, unexplained swelling of the body or tongue, or other symptoms that come on rapidly after taking the medicine and make you feel unwell (uncommon)
How common each side effect is
Grouped the way the leaflet groups them. Most people get none, or only a few. Each figure is the most that are affected, so "up to 1 in 10" can mean far fewer.
Very common
More than 1 in 10 people
- Heart valve and related disorders
- Inflammation of the pericardium (pericarditis)
- Leaking of fluid in the pericardium (pericardial effusion)
- Swelling of the feet and ankles due to accumulation of fluid in the tissues (oedema)
- Nausea (feeling sick)
Common
Up to 1 in 10 people
- Vomiting
- Indigestion
- Inflammation of the stomach lining (gastritis)
- Constipation
- Chest pain (angina pectoris) (when used with levodopa therapy)
- Shortness of breath (difficulty breathing)
- Hallucinations
- Confusion
- Sleep disturbances
- Increased libido
Show 9 moreShow fewer
- Headache
- Somnolence (extreme drowsiness)
- Dizziness/vertigo
- Involuntary movements
- Low blood pressure (which can result in dizziness particularly on standing up)
- Lack of bodily strength
- Blood problems including low blood count (symptoms may include tiredness)
- Abnormal liver function tests
- Decreased haemoglobin and/or red blood cells
Uncommon
Up to 1 in 100 people
- Allergic reaction (widespread itchy rash, difficulty breathing with or without wheezing, feeling faint, unexplained swelling of the body or tongue)
- Redness, swelling and pain in the extremities of the arms and legs (erythromelalgia)
- Excessive abnormal movements
- Fluid in the layers of the membrane lining the lungs and chest cavity (pleural effusion)
- Developing excess fibrous tissue in the lungs (pulmonary fibrosis)
- Delusions
- Psychotic disorder
- Skin rash
- Abnormal liver function
- Fatigue
Very rare
Up to 1 in 10,000 people
- Formation of fibrous tissues (including fibrosis affecting the pleura)
Not known
The leaflet says how often is not known
- Sudden sleep attacks
- Tremor
- Loss of consciousness
- Leg cramps
- Aggressive behaviour
- Visual impairment
- Respiratory disorders and failure
- Inflammation and pain of the membrane surrounding the lungs (pleuritis)
- Chest pain
- Vasospasm (tightening in your blood vessels) in fingers and toes
Show 2 moreShow fewer
- Hair loss (alopecia)
- Increased blood values of a specific enzyme called creatinine phosphokinase
Not stated
The leaflet gives no frequency
- Strong impulse to gamble excessively despite serious personal or family consequences
- Altered or increased sexual interest and behaviour of significant concern, for example an increased sexual drive
- Uncontrollable excessive shopping or spending
- Binge eating (eating large amounts of food in a short time period)
- Compulsive eating (eating more food than normal and more than is needed to satisfy your hunger)
If you get a side effect, you can report it to the regulator through the Yellow Card scheme.
Pregnancy and breastfeeding
Use adequate contraception while taking this medicine, and ask your doctor for advice before taking it if you are pregnant, think you may be pregnant or are planning a baby. Do not breast-feed while taking it because it may affect milk production; use another method of feeding your baby.
Taking it with other medicines
The leaflet says to tell your doctor or pharmacist if you take any of these. This list is not checked against the medicines you take.
- Any other medicines, including those obtained without a prescription
- Certain medicines used for reducing blood pressure
- Phenothiazines, butyrophenones and thioxanthene (used for schizophrenia or psychoses)
- Other ergot alkaloids
- Medicines to prevent vomiting (metoclopramide)
- Macrolide antibiotics (such as erythromycin)
Where this comes from
Everything on this page is taken from one official document: the patient information leaflet that the UK medicines regulator (MHRA) approved for this product. Pestle reorganises it and puts it in plainer words. It adds nothing from anywhere else and does not rate medicines.
- Product
- Cabergoline 2mg Tablets
- Product licence
- PL 00289/0990
- Leaflet dated
- Checked against the leaflet
- Automated check
- 51 of 52 side effects matched to the wording of the leaflet. 1 could not be matched and need a manual check
Other makers of cabergoline publish their own leaflets, which can differ slightly. Always read the leaflet that came with your medicine.
Read the official leaflet Original on the MHRA site How we make these pages